CEN/TC 140
| Registration number (WIID) | Project No. | Title | Status |
|---|---|---|---|
| 75465 | LVS CEN/TS 17981-2:2023 | In vitro diagnostic Next Generation Sequencing (NGS) workflows - Part 2: Human RNA examination | Standarts spēkā |
| 70929 | LVS EN ISO 18113-1:2024 | In vitro diagnostic medical devices - Information supplied by the manufacturer (labelling) - Part 1: Terms, definitions, and general requirements (ISO 18113-1:2022) | Standarts spēkā |
| 5107 | LVS EN 13641:2003 | Elimination or reduction of risk of infection related to in vitro diagnostic reagents | Standarts spēkā |
| 68157 | EN ISO 15189:2022 | Medical laboratories - Requirements for quality and competence (ISO/DIS 15189:2021) | Standarts spēkā |
| 70518 | LVS EN ISO 6717:2021 | In vitro diagnostic medical devices - Single-use containers for the collection of specimens from humans other than blood (ISO 6717:2021) | Standarts spēkā |
| 75465 | CEN/TS 17981-2:2023 | In vitro diagnostic Next Generation Sequencing (NGS) workflows - Part 2: Human RNA examination | Standarts spēkā |
| 61690 | LVS EN ISO 20166-2:2019 | Molecular in vitro diagnostic examinations - Specifications for pre-examinations processes for formalin-fixed and paraffin-embedded (FFPE) tissue - Part 2: Isolated proteins (ISO 20166-2:2018) | Standarts spēkā |
| 68138 | LVS CEN/TS 17742:2022 | Molecular in vitro diagnostic examinations - Specifications for pre-examination processes for venous whole blood - Isolated circulating cell free RNA from plasma | Standarts spēkā |
| 31365 | LVS EN ISO 19001:2013 | In vitro diagnostic medical devices - Information supplied by the manufacturer with in vitro diagnostic reagents for staining in biology (ISO 19001:2013) | Standarts spēkā |
| 5103 | LVS EN 13612:2003 | Performance evaluation of in vitro diagnostic medical devices | Standarts spēkā |
Displaying 61-70 of 275 results.